Literature DB >> 22470591

Moyamoya disease - a vasculopahty and an uncommon cause of recurrent cerebrovascular accidents.

Yasmin S Hamirani1, Mohammad Valikhani, Allison Sweney, Hafsa Khan, Mohammad Pathan.   

Abstract

Moyamoya disease is a very rare chronic cerebrovascular disease of unknown etiology characterized by recurrent ischemic or hemorrhagic strokes. Initially diagnosed in Japan and named after finding puff of smoke like collateral blood vessels around the occluded blood vessels of circle of Willis. With increase awareness this disease is now diagnosed more often. Medical and surgical treatment have been used to treat the disease, with surgical treatment been mostly experimental. Special attention should be given to the surgical treatment which has shown to have an edge over the medical treatment in some clinical trials especially in young patients with recurrent strokes to prevent progressive cognitive decline and to improve their quality of life. In our patient, who is a young man, the diagnosis was picked up late and when surgical evaluation was performed, it was considered to be fruitless with findings of nonviable brain tissue on MRI imaging.

Entities:  

Year:  2008        PMID: 22470591      PMCID: PMC3303255          DOI: 10.3941/jrcr.v2i3.10

Source DB:  PubMed          Journal:  J Radiol Case Rep        ISSN: 1943-0922


  9 in total

1.  Moyamoya disease in Washington State and California.

Authors:  Ken Uchino; S Claiborne Johnston; Kyra J Becker; David L Tirschwell
Journal:  Neurology       Date:  2005-09-27       Impact factor: 9.910

2.  Clinical features and outcome in North American adults with moyamoya phenomenon.

Authors:  Christopher L Hallemeier; Keith M Rich; Robert L Grubb; Michael R Chicoine; Christopher J Moran; DeWitte T Cross; Gregory J Zipfel; Ralph G Dacey; Colin P Derdeyn
Journal:  Stroke       Date:  2006-04-27       Impact factor: 7.914

3.  Moyamoya disease in the United States.

Authors:  Y Numaguchi; C F Gonzalez; P C Davis; A Monajati; E Afshani; J Chang; C L Sutton; R R Lee; D K Shibata
Journal:  Clin Neurol Neurosurg       Date:  1997-10       Impact factor: 1.876

4.  Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey.

Authors:  K Wakai; A Tamakoshi; K Ikezaki; M Fukui; T Kawamura; R Aoki; M Kojima; Y Lin; Y Ohno
Journal:  Clin Neurol Neurosurg       Date:  1997-10       Impact factor: 1.876

5.  Risk factors of moyamoya disease in Canada and the USA.

Authors:  S J Peerless
Journal:  Clin Neurol Neurosurg       Date:  1997-10       Impact factor: 1.876

6.  Midwest experience with moyamoya disease.

Authors:  M K Edwards-Brown; J P Quets
Journal:  Clin Neurol Neurosurg       Date:  1997-10       Impact factor: 1.876

Review 7.  Moyamoya disease: the disorder and surgical treatment.

Authors:  K Ueki; F B Meyer; J F Mellinger
Journal:  Mayo Clin Proc       Date:  1994-08       Impact factor: 7.616

8.  Cerebrovascular bypass surgery for the treatment of Moyamoya disease: unsatisfactory outcome in the patients presenting with intracranial hemorrhage.

Authors:  N Aoki
Journal:  Surg Neurol       Date:  1993-11

9.  Clinical features of moyamoya disease in the United States.

Authors:  D Chiu; P Shedden; P Bratina; J C Grotta
Journal:  Stroke       Date:  1998-07       Impact factor: 7.914

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.